This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new ways to target the G9A and GLP enzymes and understand their role in stimulant addiction. The $272,395 award, effective from April 15, 2025 to March 31, 2027, will be carried out by the Regents of the University of California, San Francisco (UCSF). The key objectives are: 1) to identify specific surfaces on the G9A/GLP enzyme complex that can be targeted for future small molecule therapies, and 2) to determine how the different G9A/GLP enzyme dimers contribute to addiction phenotypes. This will be accomplished through structural analyses using cryo-electron microscopy, cross-linking mass spectrometry, and biochemical characterization of G9A/GLP mutants. The findings will provide critical insights into the molecular mechanisms by which these epigenetic regulators influence addiction, paving the way for the development of targeted therapeutic approaches.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $272.4k | 4/4/25 |